REG - Judges ScientificPLC - Appointment of Liberum as Joint Broker

Judges ScientificAnnouncement

22/07/2019 07:05

RNS Number : 1959G
Judges Scientific PLC
22 July 2019
 


22 July 2019
Judges Scientific plc
("Judges Scientific", "Judges", the "Company" or the "Group")
Appointment of Liberum as Joint Broker
Judges Scientific, a group engaged in the buy and build of scientific instrument businesses, is pleased to announce the appointment of Liberum Capital Limited ("Liberum") as its Joint Broker with immediate effect. Shore Capital will continue to act as the Company's Nominated Adviser & Joint Broker.
- Ends -  
 
 



Judges Scientific


  


  




David Cicurel, CEO 
Brad Ormsby, Group FD 


Tel: +44 (0) 203 829 6970 


  




 
Shore Capital (Nominated Adviser & Joint Broker) 


  




Stephane Auton 
Edward Mansfield 


Tel: +44 (0) 20 7408 4090 




 
Liberum (Joint Broker) 








Bidhi Bhoma
Euan Brown


Tel: +44 (0) 20 3100 2222




  
Media enquiries: 
Alma PR (Financial Public Relations) 


  




Rebecca Sanders-Hewett 
Sam Modlin 
  


Tel: +44 (0) 20 3405 0205  
judges@almapr.co.uk 



 Notes to editors: 
Judges Scientific plc (AIM: JDG), is a group engaged in the buy and build of scientific instrument businesses.  The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005.   
The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queens' awards for innovation and export. 
 
Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, payment of increasing dividends and through organic growth which the Group encourages by creating an environment for businesses to thrive in, with support and advice for entity management teams.  
The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins. 
For further information, please visit www.judges.uk.com 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPPGUQWMUPBGCG